# Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

> **NCT04030338** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 58 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Neoplasm
- Prostate Adenocarcinoma
- Prostate Cancer Metastatic
- Metastatic Prostate Cancer

## Interventions

- **DRUG:** 18F-DCFPyL-iPSMA
- **DRUG:** 68Ga-HBED-iPSMA
- **DIAGNOSTIC_TEST:** PET/CT scan

## Key facts

- **NCT ID:** NCT04030338
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-19
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04030338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04030338, "Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04030338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*